214 related articles for article (PubMed ID: 8209345)
1. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Robertson B; Sangstad OD
Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
[No Abstract] [Full Text] [Related]
2. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
Sanghvi KP; Merchant RH
Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
[No Abstract] [Full Text] [Related]
3. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Speer CP; Robertson B; Halliday HL
Acta Paediatr; 2000 May; 89(5):510-2. PubMed ID: 10852182
[No Abstract] [Full Text] [Related]
4. Comparing surfactant products.
Prevost RR
Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
[No Abstract] [Full Text] [Related]
5. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome.
Wyble L; Santeiro ML
Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726
[No Abstract] [Full Text] [Related]
6. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Bratlid D; Farstad T
Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
[TBL] [Abstract][Full Text] [Related]
7. Surfactant replacement therapy: issues related to currently available preparations.
Bose G
Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367
[No Abstract] [Full Text] [Related]
8. Comparison of clinical responses to natural and synthetic surfactants.
Rollins M; Jenkins J; Tubman R; Corkey C; Wilson D
J Perinat Med; 1993; 21(5):341-7. PubMed ID: 8126629
[TBL] [Abstract][Full Text] [Related]
9. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
[No Abstract] [Full Text] [Related]
10. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
[No Abstract] [Full Text] [Related]
11. OSIRIS trial.
Tarnow-Mordi W
Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
[No Abstract] [Full Text] [Related]
12. Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?
Kukkonen AK; Virtanen M; Järvenpää AL; Pokela ML; Ikonen S; Fellman V
Acta Paediatr; 2000 May; 89(5):556-61. PubMed ID: 10852192
[TBL] [Abstract][Full Text] [Related]
13. Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country.
da Costa DE; Pai MG; Al Khusaiby SM
Pediatr Pulmonol; 1999 May; 27(5):312-7. PubMed ID: 10344709
[TBL] [Abstract][Full Text] [Related]
14. Criteria for use of colfosceril (Exosurf) in neonates.
Bhatt-Mehta V; Schumacher RE
Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
[No Abstract] [Full Text] [Related]
15. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
[TBL] [Abstract][Full Text] [Related]
16. Overview of clinical trials comparing natural and synthetic surfactants.
Halliday HL
Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
[TBL] [Abstract][Full Text] [Related]
18. Colfosceril palmitate. A review of the therapeutic efficacy and clinical tolerability of a synthetic surfactant preparation (Exosurf Neonatal) in neonatal respiratory distress syndrome.
Dechant KL; Faulds D
Drugs; 1991 Nov; 42(5):877-94. PubMed ID: 1723378
[TBL] [Abstract][Full Text] [Related]
19. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
Soll RF
Cochrane Database Syst Rev; 2000; (2):CD000144. PubMed ID: 10796308
[TBL] [Abstract][Full Text] [Related]
20. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
